心臓移植の世界市場レポート 2025年

心臓移植市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.3％で181億米ドルに成長します。予測期間の成長は、政府の支援と資金提供、移植プログラムの世界化、移植センターの能力向上、遠隔医療と遠隔モニタリングの統合などに起因しています。予測期間の主な動向には、技術の進歩、人工心臓や補助装置、ドナー臓器選択における人工知能（AI）などがあります。

心血管疾患の有病率の増加は、今後数年間の心臓移植市場の成長を促進すると予想されます。心血管疾患には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。心臓移植は、他の治療法に反応しない末期心不全患者の最後の治療法です。生活の質を大幅に改善し、寿命を延ばします。例えば、2024年9月、英国を拠点とする心臓血管研究の慈善団体である英国心臓財団は、現在英国で約760万人が心臓および循環器疾患に罹患しており、その内訳は男性400万人、女性360万人であると報告しました。この数は2030年までに100万人増加すると予想され、2040年までにさらに200万人増加する可能性があります。その結果、心血管疾患の有病率の増加が心臓移植市場を牽引することになります。

心臓移植市場は、臓器提供と移植に対する意識の高まりによって成長を遂げています。この認識には、ヘルスケアにおけるこれらの処置のプロセス、意義、影響に関する知識、理解、地域社会の意識が含まれます。このような意識の高まりは、心臓移植の領域で重要な役割を果たしており、ドナー・プールの拡大、レシピエントの待ち時間の短縮、患者の転帰の改善につながっています。例えば、2023年1月、米国を拠点とし科学と教育に重点を置く非営利団体、臓器分かち合い連合（United Network for Organ Sharing）は、2022年の米国における臓器移植件数は42,887件で、前年から3.7％増加したと報告しました。その内訳は、肝臓移植が9,528件、心臓移植が4,111件、肺移植が2,692件であり、臓器移植に対する意識の高まりが大きな影響を与えています。その結果、臓器提供や移植に対する意識の高まりが、心臓移植市場の主要な促進要因となっています。その内訳は、肝臓移植が9,528件、心臓移植が4,111件、肺移植が2,692件です。したがって、臓器提供や移植に対する意識の高まりが、心臓移植市場の原動力となると思われます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓移植 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の心臓移植市場：成長率分析
• 世界の心臓移植市場の実績：規模と成長, 2019-2024
• 世界の心臓移植市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓移植総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓移植市場手術の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 完全人工心臓
• 両心室ペーシング
• 補助人工心臓
• その他の手術の種類
• 世界の心臓移植市場移植により、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家移植
• 同種移植
• その他の移植
• 世界の心臓移植市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 心臓病研究所
• その他のエンドユーザー
• 世界の心臓移植市場、タイプ別人工心臓のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一時的な完全人工心臓
• 永久全人工心臓
• 世界の心臓移植市場、両心室ペーシングのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓再同期療法ペースメーカー（CRT-P）
• 心臓再同期療法除細動器（CRT-D）
• 世界の心臓移植市場、補助人工心臓のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 左心室補助装置（LVAD）
• 右心室補助装置（RVAD）
• 両心室補助装置（BIVAD）
• 世界の心臓移植市場、その他の手術タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓と肺の移植
• 異所性心臓移植

第7章 地域別・国別分析

• 世界の心臓移植市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓移植市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓移植市場：競合情勢
• 心臓移植市場：企業プロファイル
  • Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis Pharmaceuticals UK Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Roche Diagnostics Ltd.
• Mayo Clinic
• Cleveland Clinic
• AstraZeneca plc
• Massachusetts General Hospital
• Terumo Corp.
• NewYork-Presbyterian Hospital
• Cedars-Sinai Medical Center
• Maquet Holding B.V. and Co. KG.
• Teleflex Inc.
• Stanford Health Care
• Johns Hopkins Hospital
• Thoratec Corporation
• Abiomed Inc.
• Baylor St. Lukes Medical Center

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓移植市場2029：新たな機会を提供する国
• 心臓移植市場2029：新たな機会を提供するセグメント
• 心臓移植市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A heart transplant is a sophisticated surgical procedure in which a damaged or diseased heart is removed and replaced with a healthy donor heart. This intervention is crucial and can be life-saving for individuals suffering from end-stage heart failure or specific severe heart conditions.

There are several types of heart transplant surgeries, including total artificial heart, biventricular pacing, ventricular assist devices, and other specialized procedures. A total artificial heart is a mechanical device specifically engineered to take over the functions of both the left and right ventricles of the natural human heart. This category encompasses various transplant techniques like autografts, allografts, and others. The primary recipients of these procedures are hospitals, cardiac institutes, and other specialized medical facilities.

The heart transplant market research report is one of a series of new reports from The Business Research Company that provides heart transplant market statistics, including heart transplant industry global market size, regional shares, competitors with a heart transplant market share, detailed heart transplant market segments, market trends and opportunities and any further data you may need to thrive in the heart transplant industry. This heart transplant market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heart transplant market size has grown rapidly in recent years. It will grow from $11.49 billion in 2024 to $12.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.

The heart transplant market size is expected to see strong growth in the next few years. It will grow to $18.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to government support and funding, globalization of transplant programs, increasing transplant center capacity, integration of telemedicine and remote monitoring. Major trends in the forecast period include technological advancements, artificial heart and assist devices, artificial intelligence (AI) in donor organ selection.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the heart transplant market in the coming years. Cardiovascular diseases encompass a range of conditions that affect the heart and blood vessels. A heart transplant is a treatment of last resort for individuals with end-stage heart failure who have not responded to other therapies. It significantly improves the quality of life and extends life expectancy. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to increase by 1 million by 2030 and could rise by an additional 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases will drive the heart transplant market.

The heart transplant market is experiencing growth driven by an increased awareness of organ donation and transplantation. This awareness encompasses knowledge, understanding, and community consciousness regarding the processes, significance, and impact of these procedures in healthcare. This heightened awareness is playing a substantial role in the realm of heart transplants, leading to an expanded donor pool, reduced waiting times for recipients, and improved patient outcomes. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit organization focused on science and education, reported a record of 42,887 organ transplants in the US in 2022, marking a 3.7% increase from the previous year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants, underscoring the impact of this growing awareness. Consequently, the surge in awareness about organ donation and transplantation is a key driver for the heart transplant market.year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplant. Therefore, the growing awareness about organ donation and transplantation will drive the heart transplant market.

Major companies in the heart transplant market are increasingly focused on developing innovative solutions, such as heart preservation technology, to enhance patient outcomes and improve transplant success rates. This technology significantly extends the preservation time of the heart outside the body compared to traditional ice storage, leading to better outcomes and reduced complications after transplantation. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for its Investigational Device Exemption (IDE) application for heart preservation technology. This approval enabled the company to launch the "PRESERVE Clinical Trial," a prospective, multicenter, single-arm, open-label study focused on evaluating hearts transplanted after non-ischemic heart preservation from extended donors, including those from Donation after Circulatory Death (DCD). The key feature of Xvivo's heart preservation technology is its non-ischemic hypothermic perfusion system, which uses cold, oxygenated perfusion to preserve donor hearts during transport.

In August 2024, Getinge, a Sweden-based company specializing in medical technology and healthcare solutions, acquired Paragonix Technologies for an undisclosed amount. This acquisition allows Getinge to strengthen its capabilities in organ preservation and transportation, with a focus on improving patient outcomes in transplant procedures. Paragonix Technologies, a U.S.-based company, designs, manufactures, and sells devices used for the transport of organs for transplant.

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heart transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart transplant market includes revenues earned by entities by providing services such as patient evaluation and selection, waitlist management, donor heart procurement, transplant surgery, immunosuppression management, psychosocial support and complications management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heart transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heart transplant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types
• 2) By Transplant: Autograft; Allograft; Other Transplants
• 3) By End-User: Hospitals; Cardiac Institutes; Other End-Users
• Subsegments:
• 1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart
• 2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P); Cardiac Resynchronization Therapy Defibrillators (CRT-D)
• 3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)
• 4) By Other Surgery Types: Heart And Lung Transplant; Heterotopic Heart Transplant
• Companies Mentioned: Optum Inc.; Novartis Pharmaceuticals UK Ltd.; Abbott Laboratories; Medtronic plc; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Heart Transplant Market Characteristics

3. Heart Transplant Market Trends And Strategies

4. Heart Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Heart Transplant Growth Analysis And Strategic Analysis Framework

• 5.1. Global Heart Transplant PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Heart Transplant Market Growth Rate Analysis
• 5.4. Global Heart Transplant Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Heart Transplant Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Heart Transplant Total Addressable Market (TAM)

6. Heart Transplant Market Segmentation

• 6.1. Global Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Total Artificial Heart
• Biventricular Pacing
• Ventricular Assist Devices
• Other Surgery Types
• 6.2. Global Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autograft
• Allograft
• Other Transplants
• 6.3. Global Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Cardiac Institutes
• Other End-Users
• 6.4. Global Heart Transplant Market, Sub-Segmentation Of Total Artificial Heartl, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Temporary Total Artificial Heart
• Permanent Total Artificial Heart
• 6.5. Global Heart Transplant Market, Sub-Segmentation Of Biventricular Pacing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Resynchronization Therapy Pacemakers (CRT-P)
• Cardiac Resynchronization Therapy Defibrillators (CRT-D)
• 6.6. Global Heart Transplant Market, Sub-Segmentation Of Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Left Ventricular Assist Device (LVAD)
• Right Ventricular Assist Device (RVAD)
• Biventricular Assist Device (BIVAD)
• 6.7. Global Heart Transplant Market, Sub-Segmentation Of Other Surgery Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heart And Lung Transplant
• Heterotopic Heart Transplant

7. Heart Transplant Market Regional And Country Analysis

• 7.1. Global Heart Transplant Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Heart Transplant Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Heart Transplant Market

• 8.1. Asia-Pacific Heart Transplant Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Heart Transplant Market

• 9.1. China Heart Transplant Market Overview
• 9.2. China Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Heart Transplant Market

• 10.1. India Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Heart Transplant Market

• 11.1. Japan Heart Transplant Market Overview
• 11.2. Japan Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Heart Transplant Market

• 12.1. Australia Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Heart Transplant Market

• 13.1. Indonesia Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Heart Transplant Market

• 14.1. South Korea Heart Transplant Market Overview
• 14.2. South Korea Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Heart Transplant Market

• 15.1. Western Europe Heart Transplant Market Overview
• 15.2. Western Europe Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Heart Transplant Market

• 16.1. UK Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Heart Transplant Market

• 17.1. Germany Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Heart Transplant Market

• 18.1. France Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Heart Transplant Market

• 19.1. Italy Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Heart Transplant Market

• 20.1. Spain Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Heart Transplant Market

• 21.1. Eastern Europe Heart Transplant Market Overview
• 21.2. Eastern Europe Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Heart Transplant Market

• 22.1. Russia Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Heart Transplant Market

• 23.1. North America Heart Transplant Market Overview
• 23.2. North America Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Heart Transplant Market

• 24.1. USA Heart Transplant Market Overview
• 24.2. USA Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Heart Transplant Market

• 25.1. Canada Heart Transplant Market Overview
• 25.2. Canada Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Heart Transplant Market

• 26.1. South America Heart Transplant Market Overview
• 26.2. South America Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Heart Transplant Market

• 27.1. Brazil Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Heart Transplant Market

• 28.1. Middle East Heart Transplant Market Overview
• 28.2. Middle East Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Heart Transplant Market

• 29.1. Africa Heart Transplant Market Overview
• 29.2. Africa Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Heart Transplant Market Competitive Landscape And Company Profiles

• 30.1. Heart Transplant Market Competitive Landscape
• 30.2. Heart Transplant Market Company Profiles
  • 30.2.1. Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis Pharmaceuticals UK Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Heart Transplant Market Other Major And Innovative Companies

• 31.1. Roche Diagnostics Ltd.
• 31.2. Mayo Clinic
• 31.3. Cleveland Clinic
• 31.4. AstraZeneca plc
• 31.5. Massachusetts General Hospital
• 31.6. Terumo Corp.
• 31.7. NewYork-Presbyterian Hospital
• 31.8. Cedars-Sinai Medical Center
• 31.9. Maquet Holding B.V. and Co. KG.
• 31.10. Teleflex Inc.
• 31.11. Stanford Health Care
• 31.12. Johns Hopkins Hospital
• 31.13. Thoratec Corporation
• 31.14. Abiomed Inc.
• 31.15. Baylor St. Lukes Medical Center

32. Global Heart Transplant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heart Transplant Market

34. Recent Developments In The Heart Transplant Market

35. Heart Transplant Market High Potential Countries, Segments and Strategies

• 35.1 Heart Transplant Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Heart Transplant Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Heart Transplant Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer